MY186939A - Adherens junction function enhancing agent - Google Patents

Adherens junction function enhancing agent

Info

Publication number
MY186939A
MY186939A MYPI2017702182A MYPI2017702182A MY186939A MY 186939 A MY186939 A MY 186939A MY PI2017702182 A MYPI2017702182 A MY PI2017702182A MY PI2017702182 A MYPI2017702182 A MY PI2017702182A MY 186939 A MY186939 A MY 186939A
Authority
MY
Malaysia
Prior art keywords
enhancing agent
function enhancing
adherens junction
junction function
salt
Prior art date
Application number
MYPI2017702182A
Inventor
Mari Yutori
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Publication of MY186939A publication Critical patent/MY186939A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Provided are an adherens junction function enhancing agent, an E-cadherin enhancing agent, an intercellular adhesion strength enhancing agent, an epithelial barrier function enhancing agent, and a resistance enhancing agent containing at least one selected from the group consisting of ascorbyl phosphate and a salt thereof, vitamin E and a derivative thereof, copper chlorophyll and a salt thereof, and lysozyme chloride.
MYPI2017702182A 2014-12-24 2015-12-22 Adherens junction function enhancing agent MY186939A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014259645 2014-12-24
PCT/JP2015/085867 WO2016104524A1 (en) 2014-12-24 2015-12-22 Agent for enhancing adherens junction function

Publications (1)

Publication Number Publication Date
MY186939A true MY186939A (en) 2021-08-26

Family

ID=56150540

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017702182A MY186939A (en) 2014-12-24 2015-12-22 Adherens junction function enhancing agent

Country Status (5)

Country Link
JP (1) JP6755185B2 (en)
KR (1) KR20170097013A (en)
CN (2) CN107106539A (en)
MY (1) MY186939A (en)
WO (1) WO2016104524A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7412869B2 (en) * 2016-08-05 2024-01-15 小林製薬株式会社 Gum care agent and oral composition for gum care containing the same
JP7237465B2 (en) * 2018-05-25 2023-03-13 ポーラ化成工業株式会社 A screening method using the expression levels of the occludin gene, the claudin gene, and the zo-1 gene under hypoxic conditions as an indicator, an inhibitor of claudin gene expression reduction, an inhibitor of cell adhesion apparatus function deterioration, and a reduction in skin barrier function ameliorating or preventive agent
TW202012925A (en) * 2018-05-25 2020-04-01 日商寶麗化成工業股份有限公司 Method for screening for components that improve condition of aged or hypoxic skin, and method for estimating oxygen level of subdermal tissue or fibrosis level of subdermal adipocytes as index of subdermal tissue viscoelasticity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093706A (en) * 1992-03-04 2000-07-25 Bioresponse, L.L.C. Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
JPH10236935A (en) * 1996-08-02 1998-09-08 Kao Corp Oral solid preparation
JP2001055318A (en) * 1999-08-17 2001-02-27 Lion Corp Composition for oral cavity
CA2659398A1 (en) * 2006-08-02 2008-02-07 Wm. Wrigley Jr. Company Oral compositions effective for the treatment of oral cavity malodor associated with the consumption of odor-causing compounds
JP4300370B2 (en) * 2007-03-13 2009-07-22 春三 小林 Epithelial improving agent
WO2014103475A1 (en) * 2012-12-27 2014-07-03 株式会社林原 Skin-exterior anti-ageing composition and production method therefor
CN103641837B (en) * 2013-11-15 2016-03-23 云南瑞宝生物科技股份有限公司 A kind of method of chlorophyll copper sodium extracting from silkworm excrement
CN103751031A (en) * 2014-01-09 2014-04-30 广州市科玮生物技术有限公司 Mouthwash containing antimicrobial peptide and sodium copper chlorophyllin and preparation method of mouthwash

Also Published As

Publication number Publication date
JPWO2016104524A1 (en) 2017-10-05
JP6755185B2 (en) 2020-09-16
WO2016104524A1 (en) 2016-06-30
CN107106539A (en) 2017-08-29
CN111658640A (en) 2020-09-15
KR20170097013A (en) 2017-08-25

Similar Documents

Publication Publication Date Title
EP3108097A4 (en) Zinc one piece link system
EP3183708A4 (en) Location tracking system
EP3389542A4 (en) Glove donning system
EP3316537A4 (en) Dpd system
GB201716939D0 (en) Nmes garment
EP3265397A4 (en) Tabbed seal concepts
EP3206251A4 (en) Lithium-air battery
EP3648047A4 (en) Glove/logging system
EP3525611A4 (en) Apparel for athletic activities
GB2574988B (en) Neuromuscular junction: NMJ-on-chip
PL3697206T3 (en) System for sorting insects
EP3678736A4 (en) Self-shielded, integrated-control radiosurgery system
AU2016361427A8 (en) Platinum anticancer agents
EP3335243A4 (en) Tunnel barrier schottky
GB201711744D0 (en) Barrier system
EP3338577A4 (en) Vertical waistband
EP3270839B8 (en) Barrier garment
EP3270903A4 (en) Improved disulfide-containing alkyne linking agents
MY186939A (en) Adherens junction function enhancing agent
EP3531854A4 (en) Glove attachment system
EP3305255A4 (en) Vest-type maternity belt
PL3568538T3 (en) Smoke barrier system
EP3371376A4 (en) Current shield
EP3377369A4 (en) Strap locating arrangement
EP3363188A4 (en) Presence systems, presence servers and presence agents